º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Enterprise

Bath firm launched to develop ‘ground-breaking’ vaccine storage tech

Researchers at the University of Bath have formed a company which seeks to prevent jabs from ‘spoiling’ during transportation

EnsilTech chief executive Dr Asel Sartbaev.(Image: EnsiliTech)

A new company has been launched out of the University of Bath to develop “ground-breaking” technology designed to prevent vaccines from ‘spoiling’ during transportation.

Bio-tech spinout EnsilTech has been formed by chemistry researchers at the university who have been developing a new method which could allow for jabs to remain safe and effective at all temperatures.

Vaccines such as the Covid-19 Pfizer-BioNTech vaccine have to be kept at very low temperatures, making them difficult to distribute around the world. Figures from the World Health Organisation suggest 50% of all doses are wasted.

EnsilTech chief executive Dr Asel Sartbaeva explained that at 8°C and above most vaccine proteins begin to unravel, degrading their effectiveness.

Dr Sartbaeva has been working on a process called ensilication for the past decade, which involves encasing a vaccine’s active protein in a silica shell, or simple sand, in a bid to help it keep its structure when stored at room temperature or heated to 100°C.

EnsiliTech will begin its operations at Dr Sartbaeva’s lab at the University of Bath but will soon move to the Unit DX Science Incubator in Bristol – a laboratory facility targeted at start-up science and technology businesses.

Dr Sartbaeva said: “Our initial focus will be on oral animal vaccines, and we’re hopeful that we’ll have a finished product within two years. After that, our full attention will be on human vaccines, antibodies and diagnostic proteins.”

Dr Sartbaeva was funded through government innovation body Innovate º£½ÇÊÓÆµ’s ICURe (Innovation to Commercialisation of University Research) programme, an initiative aimed at research teams from º£½ÇÊÓÆµ universities with commercially promising ideas.